Investing in Testing Act of 2017

Bill: 115-hr-1348
Sponsor: full_name: Rep. Maloney, Sean Patrick [D-NY-18]
Introduced: 2017-03-02
Policy area: Health
Subjects: Congressional oversight

Environmental assessment, monitoring, research

Environmental health

Government studies and investigations

Hazardous wastes and toxic substances

Medical research

Water quality

Water use and supply
Latest action: action_date: 2017-03-17
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2017-03-02
action_desc: Introduced in House
text: <p><b>Investing in Testing Act of 2017</b></p> This bill requires the Centers for Disease Control and Prevention to study the health implications of contamination of drinking water by perfluoroalkyl and polyfluoroalkyl substances (PFASs). (PFASs can accumulate in the body and are commonly found at low levels in food, water, and the environment.)

tv_txt: I 115th CONGRESS 1st Session H. R. 1348 IN THE HOUSE OF REPRESENTATIVES March 2, 2017 Mr. Sean Patrick Maloney of New York introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To require the Director of the Centers for Disease Control and Prevention to complete a study on the human health implications of per- and polyfluoroalkyl substances (PFAS) contamination in drinking water.

1. Short title This Act may be cited as the Investing in Testing Act of 2017 . 2. Study by CDC on health implications of per- and polyfluoroalkyl substances contamination in drinking water (a) In general The Director of the Centers for Disease Control and Prevention shall— (1) not later than 60 days after the date of enactment of this Act, commence a study on the human health implications of per- and polyfluoroalkyl substances (PFAS) contamination in drinking water; and (2) not later than 2 years and 60 days after the date of enactment of this Act— (A) complete such study; and (B) submit a report to the Congress on the results of such study. (b) Authorization of appropriations To carry out this Act, there is authorized to be appropriated $15,000,000.